BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  DNAtrix Virus Expressing T-Cell Co-stimulator OX40L (CD252) Presented at the 2017 Society for Immunotherapy of Cancer Meeting

  Juan Fueyo, MD, Professor at MD Anderson Cancer Center Department of Neuro-Oncology, presented results of a comprehensive study on the oncolytic virus Delta-24-RGDOX at the 2017 Society for Immunotherapy of Cancer (SITC) Meeting, held in National Harbor, MD on November 10th - 12th.

  November 13, 2017

   · 

  2 min read
• Biotech Beach

  Ivantis FDA Clinical Trial of the Hydrus Microstent for Minimally Invasive Glaucoma Surgery (MIGS) Meets Endpoints, Exceeds Outcomes of Past MIGS Trials

  Outcomes exceed those of any MIGS pivotal trial to date.

  November 13, 2017

   · 

  6 min read
• 

  Business

  Pfizer Creates COO Role for CEO Ian Read’s Rumored Successor

  Albert Bourla, 56, has been the Group President of Pfizer’s Innovative Health Business since the beginning of 2016.

  November 13, 2017

   · 

  4 min read
• Drug Development

  Kadmon Initiates Phase II Placebo-Controlled Clinical Trial of Tesevatinib in Autosomal Dominant Polycystic Kidney Disease

  The primary endpoint is the change from baseline in height-adjusted total kidney volume at 12 months.

  November 13, 2017

   · 

  4 min read
• Drug Development

  Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults With COPD

  The NDA is supported by the companies’ Phase III program for revefenacin, which consisted of two replicate pivotal Phase III efficacy studies and a 12-month, open-label, active comparator safety study.

  November 13, 2017

   · 

  13 min read
• Drug Development

  Biothera Pharmaceuticals Presents Data Broadening Imprime PGG Mechanism of Action

  The data were presented at the Society for Immunotherapy of Cancer (SITC) annual meeting.

  November 13, 2017

   · 

  2 min read
• Business

  Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings

  Management will be available during a question-and-answer session.

  November 13, 2017

   · 

  2 min read
• Business

  Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors From UC Berkeley, to be Used for Viral Infections

  Excision BioTherapeutics is the first company to secure licenses to further explore these gene editors as they relate to infectious diseases, including HSV, HBV, HTLV-1, and many other viruses, opening up more ways than ever before to explore possible treatments and/or cures.

  November 13, 2017

   · 

  3 min read
• Business

  SnapGene and Synbio Technologies Partner to Streamline Construct Design and Synthesis

  GSL Biotech developed SnapGene to aid the visualization, design, and documentation of DNA cloning, Gibson assembly, mutagenesis, and a growing list of additional molecular biology procedures that now includes synthetic biology.

  November 13, 2017

   · 

  3 min read
• Genetown

  Replikins Release: H5N8 ‘Bird Flu’ Pandemic, Now Disruptive in South Africa, Might Have Been Controlled by Specific Replikins Vaccines and Blockers, Available Since 2013

  Replikins’ Dr. Samuel Bogoch spoke this week on the H5N8 current pandemic ‘bird flu’ H5N8 at the 3rd annual Chernack Conference at Boston University School of Medicine on Crisis & Emergency Management.

  November 13, 2017

   · 

  1 min read